IN8BIO INC (INAB)
US45674E1091 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 1,141.06% | N/A 84.61% | N/A 81.47% | N/A 84.57% | |||||||
| EBITDA YoY % growth | -1.9M | -4.96M -161.05% | -8.47M -70.77% | -14.02M -65.53% | -27.91M -99.07% | -28.504M -2.13% | N/A | N/A | N/A -73.33% | N/A -80.77% | N/A 29.79% | N/A -15.15% | N/A 76.32% | N/A 288.89% | |
| EBIT YoY % growth | -2M | -5.06M -153.00% | -8.56M -69.17% | -14.65M -71.14% | -28.52M -94.68% | -30.337M -6.37% | N/A 2.48% | N/A 17.14% | N/A -29.82% | N/A 7.22% | N/A 79.32% | N/A 643.32% | N/A 117.76% | N/A -77.12% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -1.42 10.76% | -1.01 28.87% | N/A 43.45% | N/A 47.50% | N/A -17.01% | N/A 22.47% | N/A 104.99% | N/A 2,907.52% | N/A 58.75% | N/A -77.95% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 62.76% | -0.07 64.30% | -0.07 62.42% | -0.06 59.20% | -0.05 34.79% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -3.06M 46.92% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.97M 34.58% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.15 34.78% | -0.16 | 0.01 | 8.09% |
| Q2 2024 Q2Q % growth | -0.19 29.63% | -0.17 | -0.02 | -10.88% |
| Q1 2024 Q2Q % growth | -0.20 33.33% | -0.18 | -0.02 | -10.47% |
| Q4 2023 Q2Q % growth | -0.21 43.24% | -0.16 | -0.05 | -34.27% |
| Q3 2023 Q2Q % growth | -0.23 32.35% | -0.25 | 0.02 | 7.96% |
| Q2 2023 Q2Q % growth | -0.27 28.95% | -0.28 | 0.01 | 1.96% |
| Q1 2023 Q2Q % growth | -0.30 9.09% | -0.33 | 0.03 | 8.09% |
| Q4 2022 Q2Q % growth | -0.37 -76.19% | -0.32 | -0.05 | -14.55% |
| Q3 2022 Q2Q % growth | -0.34 -36.00% | -0.30 | -0.04 | -13.64% |
| Q2 2022 Q2Q % growth | -0.38 62.00% | -0.30 | -0.08 | -28.47% |
| Q1 2022 Q2Q % growth | -0.33 | -0.34 | 0.01 | 1.96% |
| Q4 2021 Q2Q % growth | -0.21 | -0.27 | 0.06 | 22.31% |
| Q3 2021 Q2Q % growth | -0.25 | -0.28 | 0.03 | 10.87% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 45.24% | 5.88% | 11.11% |
| Revenue | N/A | N/A | N/A | N/A |